Published On: Wed, Oct 19th, 2016

Latest Analyst Reports On Medtronic, Inc.


Recently stock market analysts have updated their consensus ratings on shares of Medtronic, Inc. (NYSE:MDT).

Most recent broker ratings

09/20/2016 – Medtronic, Inc. had its “buy” rating reiterated by analysts at UBS. They now have a USD 96 price target on the stock.

08/26/2016 – Medtronic, Inc. had its “buy” rating reiterated by analysts at Needham & Company. They now have a USD 95 price target on the stock.

08/26/2016 – Medtronic, Inc. had its “buy” rating reiterated by analysts at Jefferies. They now have a USD 100 price target on the stock.

08/26/2016 – Medtronic, Inc. had its “outperform” rating reiterated by analysts at Oppenheimer. They now have a USD 94 price target on the stock.

08/23/2016 – Citigroup began new coverage on Medtronic, Inc. giving the company a “buy” rating. They now have a USD 102 price target on the stock.

07/06/2016 – Medtronic, Inc. had its “buy” rating reiterated by analysts at Goldman Sachs.

06/27/2016 – Medtronic, Inc. had its “buy” rating reiterated by analysts at Evercore ISI. They now have a USD 86.5 price target on the stock.

06/27/2016 – Medtronic, Inc. had its “neutral” rating reiterated by analysts at BTIG Research.

06/20/2016 – Medtronic, Inc. had its “hold” rating reiterated by analysts at Argus.

06/15/2016 – Medtronic, Inc. had its “overweight” rating reiterated by analysts at Piper Jaffray. They now have a USD 94 price target on the stock.

06/08/2016 – Guggenheim began new coverage on Medtronic, Inc. giving the company a “neutral” rating.

06/02/2016 – Medtronic, Inc. had its “buy” rating reiterated by analysts at Deutsche Bank. They now have a USD 92 price target on the stock.

06/01/2016 – Medtronic, Inc. had its “market perform” rating reiterated by analysts at Leerink Swann. They now have a USD 85 price target on the stock.

06/01/2016 – Medtronic, Inc. had its “neutral” rating reiterated by analysts at Wedbush. They now have a USD 82 price target on the stock.

05/12/2016 – Medtronic, Inc. had its “outperform” rating reiterated by analysts at RBC Capital. They now have a USD 87 price target on the stock.

Medtronic, Inc. has a 50 day moving average of 85.79 and a 200 day moving average of 84.12. The stock’s market capitalization is 115.46B, it has a 52-week low of 71.03 and a 52-week high of 89.27.

The share price of the company (NYSE:MDT) was up +1.19%, with a high of 83.86 during the day and the volume of Medtronic, Inc. shares traded was 3510342.

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The Company’s subsidiaries include Medtronic, Inc. and HeartWare International, Inc.